DFMO tested as follow-up treatment for medulloblastoma
Official title: DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma
Status: Recruiting. It is looking for patients now. Talk to your care team about whether it fits you.
The trial team last updated this record on .
The short version
This trial is testing a drug called DFMO in people with a brain tumor called medulloblastoma.
Read our full plain-language summary
What the trial team says
Difluoromethylornithine (DFMO) will be used in an open label, multicenter, study as Maintenance Therapy for Molecular High Risk/Very High Risk and Relapsed/Refractory Medulloblastoma.
Key facts
- Registry number
- NCT04696029
- Stage of testing
- Phase 2
- Conditions studied
- Medulloblastoma
Where it is running
This trial lists 26 sites.
-
Arkansas
- Arkansas Children's Hospital (Little Rock)
-
California
- UCSF Benioff Children's Hospital Oakland (Oakland)
- UC Davis Comprehensive Cancer Center (Sacramento)
- Rady Children's Hospital (San Diego)
- Stanford University (Stanford)
-
Connecticut
- Connecticut Children's Hospital (Hartford)
-
Florida
- Nicklaus Children's Hospital (Miami)
- Arnold Palmer Hospital for Children (Orlando)
- All Children's Hospital Johns Hopkins Medicine (St. Petersburg)
- St. Joseph's Children's Hospital (Tampa)
-
Hawaii
- Kapiolani Medical Center for Women and Children (Honolulu)
-
Illinois
- Advocate Aurora Research Institute (Chicago)
-
Kentucky
- Kentucky Children's Hospital (Lexington)
- Norton Children's Research Institute/Affiliated with University of Louisville School of Medicine (Louisville)
-
Missouri
- Children's Mercy Hospitals and Clinics (Kansas City)
- Cardinal Glennon Children's Medical Center (St Louis)
-
New Jersey
- Hackensack University Medical Center (Hackensack)
-
North Carolina
- Levine Children's Hospital (Charlotte)
- Duke University (Durham)
-
Oklahoma
- University of Oklahoma (Oklahoma City)
-
Oregon
- Randall Children's Hospital (Portland)
-
Pennsylvania
- Penn State Milton S. Hershey Medical Center and Children's Hospital (Hershey)
-
Quebec
- CHUQ (Québec)
-
Rhode Island
- Hasbro Children's Hospital (Providence)
-
South Carolina
- Medical University of South Carolina (Charleston)
-
Texas
- Dell Children's Blood and Cancer Center (Austin)
How to use this
Talk to your care team first. They know your history and can tell you whether this trial is worth your time.
Joining a trial is always your choice. A trial is a test, not a proven treatment. Being in one is not a promise that it will help you.
This page is built from the trial's listing on ClinicalTrials.gov, a service of the U.S. National Library of Medicine. That listing is the authority, and it may have changed since we last read it. We do not run this trial and we cannot enroll you in it.